ARCHIVES

Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: PAs Available.

January 28, 2005

RFA, “New Approaches In Surgical Oncology” Announced By DCT

December 1, 1978

Organ Site Review Committee Recommends Continuing Program Despite Some Weak Areas, Suggests Changes

February 5, 1982

Two-Drug Combination Extends Survival Of Mesothelioma

May 31, 2002

ASCO Advises KRAS Testing In Patients With Metastatic Colorectal Cancer

January 30, 2009

Controversy Raging On Whether To Release Data On 5-FU/Levamisole, Stop Untreated Control Arm

June 9, 1989